Heather A. Wakelee
Impact in
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 204
- Lung Cancer Diagnosis and Treatment 80
- Brain Metastases and Treatment 16
- Oncology 164
- Lung Cancer Research Studies 56
- Cancer Immunotherapy and Biomarkers 41
- Colorectal Cancer Treatments and Studies 33
- Co-authors
- Joel W. Neal (120 shared papers)Billy Wiseman Loo Jr. (35 shared papers)Maximilian Diehn (34 shared papers)Joseph B. Shrager (15 shared papers)Arash Ash Alizadeh (6 shared papers)Aaron M. Newman (6 shared papers)Scott Victor Bratman (3 shared papers)Chih Long Liu (2 shared papers)
- Journals
- Journal of Thoracic Oncology (87 papers)Clinical Lung Cancer (38 papers)Annals of Oncology (27 papers)International Journal of Radiation Oncology*Biology*Physics (23 papers)Lung Cancer (23 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Heather A. Wakelee
408 papers receiving 24.8k citations
Heather A. Wakelee's Hit Papers
Peers
Comparison fields: 5 of 160
- Cancer Research 7.1k
- Pulmonary and Respiratory Medicine 11.7k
- Oncology 9.7k
- Pathology and Forensic Medicine 1.7k
- Molecular Biology 5.6k
Countries citing papers authored by Heather A. Wakelee
This map shows the geographic impact of Heather A. Wakelee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather A. Wakelee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather A. Wakelee more than expected).
Fields of papers citing papers by Heather A. Wakelee
This network shows the impact of papers produced by Heather A. Wakelee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather A. Wakelee. The network helps show where Heather A. Wakelee may publish in the future.
Co-authors
The 25 scholars most cited alongside Heather A. Wakelee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 436 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage Hit paper breakdown → | 2014 | 1819 |
| 2 | Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry Hit paper breakdown → | 2019 | 1055 |
| 3 | Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial Hit paper breakdown → | 2021 | 1046 |
| 4 | Integrated digital error suppression for improved detection of circulating tumor DNA Hit paper breakdown → | 2016 | 872 |
| 5 | Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling Hit paper breakdown → | 2017 | 827 |
| 6 | Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer Hit paper breakdown → | 2023 | 693 |
| 7 | Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer Hit paper breakdown → | 2015 | 595 |
| 8 | Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients Hit paper breakdown → | 2016 | 561 |
| 9 | Integrating genomic features for non-invasive early lung cancer detection Hit paper breakdown → | 2020 | 534 |
| 10 | Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC Hit paper breakdown → | 2018 | 528 |
| 11 | First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers Hit paper breakdown → | 2019 | 497 |
| 12 | Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer Hit paper breakdown → | 2021 | 496 |
| 13 | Lung Cancer Incidence in Never Smokers Hit paper breakdown → | 2007 | 495 |
| 14 | COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study Hit paper breakdown → | 2020 | 484 |
| 15 | American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy Hit paper breakdown → | 2011 | 426 |
| 16 | Heterogeneity Underlies the Emergence of EGFR T790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor Hit paper breakdown → | 2015 | 424 |
| 17 | 2018 | 392 | |
| 18 | Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients With ALK -Rearranged Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2 Hit paper breakdown → | 2016 | 312 |
| 19 | 2017 | 298 | |
| 20 | 2020 | 291 |
About Heather A. Wakelee
Heather A. Wakelee is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Neurology and Pathology and Forensic Medicine, having authored 436 papers that have together received 25.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (204 papers), Lung Cancer Diagnosis and Treatment (80 papers), Lung Cancer Research Studies (56 papers), Cancer Immunotherapy and Biomarkers (41 papers), Cancer Genomics and Diagnostics (40 papers), Colorectal Cancer Treatments and Studies (33 papers), Myasthenia Gravis and Thymoma (23 papers) and Brain Metastases and Treatment (16 papers). The work is most often cited by research in Cancer Research (7.1k citations), Pulmonary and Respiratory Medicine (11.7k citations), Oncology (9.7k citations), Pathology and Forensic Medicine (1.7k citations) and Molecular Biology (5.6k citations). Heather A. Wakelee has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Joel W. Neal, Billy Wiseman Loo Jr., Maximilian Diehn, Joseph B. Shrager, Arash Ash Alizadeh, Aaron M. Newman, Scott Victor Bratman, Chih Long Liu, Sukhmani Kaur Padda and Neville C. W. Eclov. Their work appears in journals such as Journal of Thoracic Oncology, Clinical Lung Cancer, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.